by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
Rockville, MD, Sept. 12, 2016 (GLOBE NEWSWIRE) — and Osaka, Japan, Sept. 12, 2016 — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the commencement by HEALIOS...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
San Francisco, Sept. 12, 2016 (GLOBE NEWSWIRE) — The neurostimulation devices market is expected to reach USD 9.8 billion by 2024, according to a new report by Grand View Research, Inc. The neurostimulation devices market is anticipated to witness a significant...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 12, 2016 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) announced that, as expected, the independent data monitoring committee (DMC) has completed its review of the first pre-specified interim efficacy...
by GlobeNewsWire | Sep 9, 2016 | Globe Newswire
NEW YORK, Sept. 09, 2016 (GLOBE NEWSWIRE) — OHA Investment Corporation (NASDAQ:OHAI) (the “Company”) today announced that it has closed a new $56.5 million secured term loan credit facility (“Credit Facility”) with MidCap Financial, which replaces the Company’s...